{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-08",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Hattiesburg",
      "state": "MS",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "90982",
      "recalling_firm": "Pharmacy Plus, Inc. dba Vital Care Compounder",
      "address_1": "115 S 40th Ave",
      "address_2": "N/A",
      "postal_code": "39402-6600",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Telephone",
      "distribution_pattern": "AL, LA, MS, and TN",
      "recall_number": "D-0031-2023",
      "product_description": "CEFUROXIME INTRAVITREAL SYR 1MG/0.1ML Solution in 1 mL syringe, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS  39402",
      "product_quantity": "460 syringes",
      "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.",
      "recall_initiation_date": "20221007",
      "center_classification_date": "20221102",
      "report_date": "20221109",
      "code_info": "Lots: 63265, BUD: 01/24/2023; 66085, BUD: 04/03/2023"
    }
  ]
}